NCT00509847View on ClinicalTrials.gov

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis

PHASE1/PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

October 31, 2009

Conditions

Staphylococcal InfectionsBacteremia

Interventions

DRUG

human lactoferrin peptide 1-11

(A) hLF1-11 (once-daily 0.5mg IV for 10 days): Group #1, n=10; OR (B) Placebo (to match hLF1-11): Group #2, n=10

Trial Locations (1)

6500 HB

UMC St. Radboud, Nijmegen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AM-Pharma

INDUSTRY